Phase 1/2 Study of PX-866 and Docetaxel in Patients With Solid Tumors.

Trial Profile

Phase 1/2 Study of PX-866 and Docetaxel in Patients With Solid Tumors.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Jun 2016

At a glance

  • Drugs Sonolisib (Primary) ; Docetaxel
  • Indications Head and neck cancer; Non-small cell lung cancer; Solid tumours
  • Focus Therapeutic Use
  • Sponsors Cascadian Therapeutics
  • Most Recent Events

    • 18 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Nov 2013 Planned end date changed from 1 Feb 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
    • 01 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top